Intuitive Surgical stock trades on Nasdaq as da Vinci drives growth

Intuitive Surgical stock remains a Nasdaq name built around robotic-assisted surgery and the da Vinci platform. The company continues to anchor its business in hospital procedures, instruments, and service revenue.

Intuitive Surgical, Inc. (ISIN US46120E6023) trades on Nasdaq and is best known for its da Vinci robotic-assisted surgery platform, a business model that centers on recurring instrument, accessory, and service revenue.

Business model

The company sells robotic systems used in minimally invasive surgery, while hospitals and surgical centers also buy disposable instruments and support services tied to procedure volume. That mix gives the business a recurring-revenue layer that is structurally different from a one-time equipment sale.

Investor context

For investors, the key structural point is that procedure growth matters as much as system sales, because each installed robot can support follow-on revenue over time. That makes the installed base and utilization rate more important than a simple hardware shipment count.

da Vinci focus

da Vinci is the representative product most closely tied to the company's brand and revenue engine. It is also the clearest lens for understanding why the stock's long-term debate centers on procedure adoption, clinical breadth, and competitive positioning.

Stock context

Intuitive Surgical stock trades on Nasdaq in U.S. dollars. As of July 11, 2026, the quoted market price was not available in the provided search results, so no verified live price is included here.

Fact box

• Company: Intuitive Surgical, Inc.
• ISIN: US46120E6023
• Ticker: ISRG
• Exchange: Nasdaq
• Sector / Industry: Health Care / Medical Devices